// App-Quantinova.ai

T2122 2016 AHA : Comparative Effectiveness and Clinical Safety Between Dabigatran, Rivaroxaban, and Warfarin

Researchers

Presenter

  • Ho-Min Chen

Principal Investigators

  • Ting-Tse Lin

  • Min-Tsun Liao

  • K. Arnold Chan

Medical Centers

  • Natl Taiwan Univ Hosp HsinChu Branch, Hsinchu City, Taiwan

  • Natl Taiwan Univ Hosp, Taipei, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Arrhythmia

  • Peripheral arterial embolism

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved